News

BioPerfectus HBV Real Time PCR Kit Receives Approval from NMPA

News
2024-03-26

🎉Product News: We are thrilled to announce that our Hepatitis B Virus Real Time PCR Kit has received official approval from the NMPA (National Medical Product Administration) in China!

The NMPA plays a pivotal role in ensuring the safety and efficacy of medical devices within China. The registration process ensures that these medical devices meet the required safety and effectiveness standards set by the Chinese government.

Accurate diagnostics are fundamental to precise treatment. This kit utilizes a quantitative fluorescence PCR technique to accurately detect the concentration of HBV.  It features high sensitivity, with a limit of detection of 5 IU/ml. This threshold meets the current highest standard for detection sensitivity recommended by global guidelines.🧬

Key features of the kit include:

🌟Ultra-high sensitivity: With a limit of detection of 5 IU/ml.

🌟A wide linear range: Ranging from 10 IU/ml to 1.0×10^9 IU/ml.

🌟 Reliability: UDG enzyme to prevent contamination.

🌟 Easy operation: Providing scalable automation solution using BioPerfectus automated nucleic acid extraction systems.

🌟Wide compatibility: Suitable for multiple mainstream instruments, such as ABI 7500 Real-Time PCR System, QuantStudio™ 5 Real-Time PCR System, BioPerfectus STC-96A/96A PLUS Real-Time PCR System, and Roche's LightCycler 480 PCR System.

ℹ️Learn more:

https://www.bioperfectus.com/ProductDetail/HepatitisBVirusRealTimePCRKitRUO